Author:
Begemann Marieke,Leon Mikela,van der Horn Harm Jan,van der Naalt Joukje,Sommer Iris
Abstract
AbstractOutcome after traumatic brain injury (TBI) varies largely and degree of immune activation is an important determinant factor. This meta-analysis evaluates the efficacy of drugs with anti-inflammatory properties in improving neurological and functional outcome. The systematic search following PRISMA guidelines resulted in 15 randomized placebo-controlled trials (3734 patients), evaluating progesterone, erythropoietin and cyclosporine. The meta-analysis (15 studies) showed that TBI patients receiving a drug with anti-inflammatory effects had a higher chance of a favorable outcome compared to those receiving placebo (RR = 1.15; 95% CI 1.01–1.32, p = 0.041). However, publication bias was indicated together with heterogeneity (I2 = 76.59%). Stratified analysis showed that positive effects were mainly observed in patients receiving this treatment within 8 h after injury. Subanalyses by drug type showed efficacy for progesterone (8 studies, RR 1.22; 95% CI 1.01–1.47, p = 0.040), again heterogeneity was high (I2 = 62.92%) and publication bias could not be ruled out. The positive effect of progesterone covaried with younger age and was mainly observed when administered intramuscularly and not intravenously. Erythropoietin (4 studies, RR 1.20; p = 0.110; I2 = 76.59%) and cyclosporine (3 studies, RR 0.75; p = 0.189, I2 = 0%) did not show favorable significant effects. While negative findings for erythropoietin may reflect insufficient power, cyclosporine did not show better outcome at all. Current results do not allow firm conclusions on the efficacy of drugs with anti-inflammatory properties in TBI patients. Included trials showed heterogeneity in methodological and sample parameters. At present, only progesterone showed positive results and early administration via intramuscular administration may be most effective, especially in young people. The anti-inflammatory component of progesterone is relatively weak and other mechanisms than mitigating overall immune response may be more important.
Publisher
Springer Science and Business Media LLC
Reference59 articles.
1. Finnie, J. Neuroinflammation: Beneficial and detrimental effects after traumatic brain injury. Inflammopharmacology 21, 309–320 (2013).
2. Narayan, R. K. et al. Clinical trials in head injury. J. Neurotrauma 19, 503–557 (2002).
3. Benedictus, M. R., Spikman, J. M. & van der Naalt, J. Cognitive and behavioral impairment in traumatic brain injury related to outcome and return to work. Arc. Phys. Med. Rehabil. 91, 1436–1441 (2010).
4. Cifu, D. & Caruso, D. Traumatic Brain Injury: Rehabilitation Medicine Quick Reference 1st edn. (New York, Demos Medical Publishing, 2010).
5. Cederberg, D. & Siesjö, P. What has inflammation to do with traumatic brain injury?. Childs Nerv. Syst. 26, 221–226 (2010).
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献